Zomig (Zolmitriptan nasal spray) AstraZeneca

News
Article

Migraine therapy available in a nasal spray formulation

Newsletter

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!
Recent Videos
Related Content
Intercept Withdraws Ocaliva from Market After FDA Raises Safety Concerns

Intercept Withdraws Ocaliva from Market After FDA Raises Safety Concerns

Denise Myshko
September 16th 2025
Article

Read More

David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2

David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2

Briana Contreras
September 16th 2025
Podcast

Listen

ICER Finds GLP-1 Drugs Cost-Effective but Warns of Major Budget Strain

ICER Finds GLP-1 Drugs Cost-Effective but Warns of Major Budget Strain

Denise Myshko
September 16th 2025
Article

Read More

Nomad_Soul-stock@adobe.com

Updated: FDA Approves Leqembi Autoinjector for Maintenance Dosing in Alzheimer’s

Denise Myshko
September 16th 2025
Article

Read More

Peter Togel-stock@adobe.com

Teva Launches First Generic GLP-1 Drug for Obesity

Formulary Watch
September 16th 2025
Article

Read More

freebird7977-stock@adobe.com

Novo Nordisk Teams with Form Health, 9amHealth for Obesity Care

Denise Myshko
September 16th 2025
Article

Read More

© 2025 MJH Life Sciences

All rights reserved.